XML 22 R4.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
¥ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
USD ($)
$ / shares
shares
Dec. 31, 2019
CNY (¥)
¥ / shares
shares
Dec. 31, 2018
CNY (¥)
¥ / shares
shares
Dec. 31, 2017
CNY (¥)
¥ / shares
shares
Revenues, net of value-added tax $ 28,493 ¥ 198,363 ¥ 190,898 ¥ 330,977
Equipment leasing revenues 8,412 58,559 76,723 239,569
Revenue 20,081 139,804 114,175 91,408
Cost of revenues (30,767) (214,193) (171,136) (232,979)
Gross profit (2,274) (15,830) 19,762 97,998
Operating expenses:        
Selling expenses (4,344) (30,241) (21,718) (43,608)
General and administrative expenses (45,266) (315,134) (291,854) (237,646)
Impairment of long-lived assets (10,930) (76,089) (5,433) (28,600)
Operating loss (62,814) (437,294) (299,243) (211,856)
Interest expense (including interest expense to related party amounting to RMB31,716, RMB193 and RMB151 (US$22) for the years ended December 31, 2017, 2018 and 2019, respectively) (4,122) (28,700) (46,232) (89,959)
Foreign exchange gain, net 5,026 34,990 36,531 4,023
(Loss) gain on disposal of long-lived assets (187) (1,299) 4,711 (31,437)
Interest income 1,316 9,165 14,168 12,077
Income (loss) from equity method investments (729) (5,078) (20,747) 1,454
Gain on disposal of subsidiaries 0 0 3,341 58,913
Other income, net 5,335 37,138 34,206 2,890
Gain on disposal of an equity method investment 0 0 48,019 0
Loss before income tax (56,175) (391,078) (225,246) (253,895)
Income tax (expenses) benefit 5,600 38,986 (34,051) (31,789)
Net loss (50,575) (352,092) (259,297) (285,684)
Net loss attributable to noncontrolling interests (6,470) (45,043) (24,422) (1,364)
Net loss attributable to Concord Medical Services Holdings Limited $ (44,105) ¥ (307,049) ¥ (234,875) ¥ (284,320)
Loss per share for Class A and Class B ordinary shares:        
Basic and diluted | (per share) $ (0.61) ¥ (4.24) ¥ (2.76) ¥ (2.19)
Weighted average number of class A and class B ordinary shares outstanding:        
Basic and diluted 130,238,498 130,238,498 130,104,787 130,091,977
Other comprehensive income (loss), net of tax of nil        
Foreign currency translation, net tax of nil $ (1,245) ¥ (8,664) ¥ (41,203) ¥ 40,550
Total other comprehensive income (loss), net of tax (1,245) (8,664) (41,203) 40,550
Comprehensive loss (51,820) (360,756) (300,500) (245,134)
Comprehensive income (loss) attributable to noncontrolling interests (6,310) (43,930) (22,902) 2,485
Comprehensive loss attributable to Concord Medical Services Holdings Limited (45,510) (316,826) (277,598) (247,619)
Services and other revenues        
Revenue 16,809 117,027 99,117 91,351
Medicine income        
Revenue $ 3,272 ¥ 22,777 ¥ 15,058 ¥ 57